First Trust NYSE Arca Biotechnology Index Fund
107 hedge funds and large institutions have $297M invested in First Trust NYSE Arca Biotechnology Index Fund in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 58 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
107
Holders Change
-22
Holders Change %
-17.05%
% of All Funds
2.86%
Holding in Top 10
5
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-50%
% of All Funds
0.13%
New
17
Increased
15
Reduced
58
Closed
37
Calls
$876K
Puts
$849K
Net Calls
+$27K
Net Calls Change
-$5.28M
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
$7.51M |
| 2 |
Jane Street
New York
|
$8.08M |
| 3 |
TH
Timber Hill
Greenwich,
Connecticut
|
$2.55M |
| 4 |
VF
Virtu Financial
New York
|
$2.54M |
| 5 |
SG Americas Securities
New York
|
$2.54M |
Top Sellers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
$0 |
| 2 |
Morgan Stanley
New York
|
$42.4M |
| 3 |
Wells Fargo
San Francisco,
California
|
$40.2M |
| 4 |
UBS Group
Zurich,
Switzerland
|
$22.5M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
$22.2M |
